NSE filing, NSE: PRAMODINI. Summary written from the filing by ALFA Finder's alert engine.
Pramodini Medicare Ltd: key numbers
- Share price
- ₹109.00
- Market cap
- ₹240.3 Cr
- Revenue (annual)
- ₹62.29 Cr
- Net profit (annual)
- ₹17.38 Cr
- P/E (TTM)
- 13.8×Sector 45.8×
- Promoter holding
- 62.64%
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pramodini Medicare Ltd
All →Pramodini Medicare Other Announcement
Pramodini Medicare Limited has appointed Purva Sharegistry India Pvt Ltd as its Registrar and Share Transfer Agent in compliance with SEBI regulations.
Pramodini Medicare Management Change
Pramodini Medicare Limited has appointed Mr. Rushikesh Vijay Gosavi as Company Secretary and Compliance Officer, effective 01st November 2025 and 21st March 2026 respectively.
Pramodini Medicare Merger & Restructuring
Pramodini Medicare Limited incorporated a new subsidiary, Sidheart Advanced Healthcare Private Limited, to operate a cardiac facility in Kodagu, Karnataka.
Pramodini Medicare Merger & Restructuring Worth ₹0.03 Cr
Pramodini Medicare Ltd incorporated a new subsidiary, Sidheart Advanced Healthcare Private Ltd, to operate a cardiac facility. The company acquired a 30% stake in the entity.
- Value
- ₹0.03 Cr
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.